Fatty-acid SPECT imaging for assessment of myocardial viability
Publisher
Springer Netherlands
Reference46 articles.
1. Evans JR, Gunton RW, Baker RG et al. Use of radioiodinated fatty acid for photoscans of the heart. Circ Res 1965;16:1–10.
2. Gunton RW, Evans JR, Baker RG, Spears JC, Beanlands DS. Demonstration of myocardial infarction by photoscans of the heart in man. Am J Cardiol 1965;16:482–487.
3. Visser FC, Westera G, Van Eenige MJ, Van der Wall EE, Den Hollander W, Roos JP. The myocardial elimination rate of radioiodinated heptadecanoic acid. Eur J Nucl Med 1985;10:118–122.
4. Van der Wall EE, Heidendal GA, den Hollander W, Westera G, Roos JP. I-123 labeled hexadecanoic acid in comparison with thallium-201 for myocardial imaging in coronary heart disease. Eur J Nucl Med 1980:5:401–405.
5. Van der Wall EE, Heidendal GA, den Hollander W, Westera G, Roos JP. Metabolic myocardial imaging with 123-I labeled heptadecanoic acid in patients with angina pectoris. Eur J Nucl Med 1981;6:391–396.